CABYRP1

Across TCGA pan-cancer cohorts, CABYRP1 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated CABYRP1 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher CABYRP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CABYRP1 expression acts as an unfavorable survival marker, although some lineages such as LUSC and CESC show a favorable association.

CHOL, LUSC, and CESC are the cancer types where CABYRP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	DFS	Tertile	II,III,IV	0.016	0.406	<.001	72	view →
LUSC	OS	Tertile	All	0.504	0.362	.002	62	view →
CESC	DFS	Tertile	II,III,IV	0.955	0.653	.008	54	view →
LUAD	DFS	Tertile	III,IV	0.296	0.694	.003	39	view →
SKCM	DFS	Tertile	II,III,IV	0.112	0.268	.011	33	view →
KIRC	DFS	Tertile	All	0.769	0.871	.007	30	view →
THCA	DFS	Tertile	All	0.715	0.937	.001	30	view →
STAD	DFS	Tertile	IV	0.805	0.206	.022	18	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
PCPG	OS	Tertile	All	0.516	0.947	.009	18	view →
DLBC	DFS	Tertile	All	0.399	0.796	.032	18	view →
SARC	DFS	Tertile	All	0.347	0.534	.018	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

CABYRP1–CHOL (DFS)

Open the CHOL breakdown →